In response to Liu et al

Affiliations

¹ Department of Radiation Oncology, Hyogo Ion Beam Medical Center Kobe Proton Center, Japan; Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Japan.
² QST Hospital, Quantum Medical Science Directorate, National Institute for Quantum and Radiological Sciences and Technology, Inage, Japan.
³ Department of Radiation Oncology, Japanese Red Cross Maebashi Hospital, Maebashi, Japan.
⁴ Ion Beam Therapy Center, SAGA-HIMAT Foundation, Tosu, Japan.
⁵ Gunma University Heavy Ion Medical Center, Maebashi, Japan.
⁶ Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Japan.
⁷ Department of Radiation Oncology, Yamagata University, Faculty of Medicine, Japan.
⁸ National Institute of Radiological Sciences, Quantum Medical Science Directorate, National Institute for Quantum and Radiological Sciences and Technology, Inage, Japan.
⁹ Ion-beam Radiation Oncology Center, Kanagawa Cancer Center, Yokohama, Japan. Electronic address: tkamadakcch2@gmail.com.

Comment

Yusuke Demizu et al. Radiother Oncol. 2021 Feb.

. 2021 Feb:155:e18-e19.

doi: 10.1016/j.radonc.2020.11.016. Epub 2020 Nov 20.

¹ Department of Radiation Oncology, Hyogo Ion Beam Medical Center Kobe Proton Center, Japan; Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Japan.
² QST Hospital, Quantum Medical Science Directorate, National Institute for Quantum and Radiological Sciences and Technology, Inage, Japan.
³ Department of Radiation Oncology, Japanese Red Cross Maebashi Hospital, Maebashi, Japan.
⁴ Ion Beam Therapy Center, SAGA-HIMAT Foundation, Tosu, Japan.
⁵ Gunma University Heavy Ion Medical Center, Maebashi, Japan.
⁶ Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Japan.
⁷ Department of Radiation Oncology, Yamagata University, Faculty of Medicine, Japan.
⁸ National Institute of Radiological Sciences, Quantum Medical Science Directorate, National Institute for Quantum and Radiological Sciences and Technology, Inage, Japan.
⁹ Ion-beam Radiation Oncology Center, Kanagawa Cancer Center, Yokohama, Japan. Electronic address: tkamadakcch2@gmail.com.

No abstract available

Keywords: Carbon ion radiotherapy; Multicentre study; Sacral chordoma.

Comment on

Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan.
Demizu Y, Imai R, Kiyohara H, Matsunobu A, Okamoto M, Okimoto T, Tsuji H, Ohno T, Shioyama Y, Nemoto K, Nakano T, Kamada T; Japan Carbon-Ion Radiation Oncology Study Group. Demizu Y, et al. Radiother Oncol. 2021 Jan;154:1-5. doi: 10.1016/j.radonc.2020.09.018. Epub 2020 Sep 14. Radiother Oncol. 2021. PMID: 32941958
Letter to the editor of radiotherapy and oncology regarding the article "Carbon ion radiotherapy for sacral chordoma: A retrospective nationwide multicentre study in Japan" by Demizu et al.
Liu FS, Liu FB, Zhang QS, Wang XB, Zou MX, Li J. Liu FS, et al. Radiother Oncol. 2021 Feb;155:e16-e17. doi: 10.1016/j.radonc.2020.11.017. Epub 2020 Nov 20. Radiother Oncol. 2021. PMID: 33227355 No abstract available.